CLABFCore One Labs Inc.

About Core One Labs Inc. (CLABF)

Core One Labs Inc. (CLABF) is a Biotechnology company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Core One Labs Inc. is a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The Company has developed a patent pending thin film oral strip (the "technology") which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining excellent bioavailability. With this technology, the Company intends to further develop its IP technology to focus on delivering psychedelic molecules with an initial focus on psilocybin. Core One also holds an interest in walk-in medical clinics which maintain a database of over 200,000 patients combined. Through research and development in these clinics, including the integration of its intellectual property related to psychedelic treatments and novel drug therapies, the Company intends to work towards regulatory approval for research that advances psychedelic-derived treatments for mental health disorders.

Products and services

Core One Labs Inc. (“COOL” or the “Company”) is a research and development stage natural psychedelic drug development company that adopts a multi-faceted business approach to incorporate complementary lines of business and business units to establish itself as an industry leader in the rapidly growing and emerging psychedelics market space. The Company holds five patents related to psychedelic compounds and drug candidate formulations. These drug candidates are being developed in the pre-clinical stage for treatments towards stroke, Parkinson’s disease, Alzheimer’s disease, and depression. The Company owns and partially owns a total of four medical clinics, three in Canada and one in the United States, that have a combined patient base of over 275,000 individuals that are receptive to alternative medicine treatments.

CLABF key facts

Ticker symbol

CLABF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2010

Employees

6

Estimated market cap

$2.83M (as of Apr 16, 2025)

Shares outstanding

47,097,332

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

3/31

Latest filing

Interim Financial Report (Dec 31, 2023)

Core One Labs Inc. leadership

• Joel Sebastien Raife Shacker — CEO
• Geoffrey John Balderson — CFO, Corporate Secretary
• Santiago Ferro — CSO
• Nicole Dominique Lacson — Administrator
• Jennifer Lesley Wong — Administrator
• Accounts Payable — Other

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C